FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1515261000168108: hyaluronate sodium 30 mg / 1 mL + sodium chondroitin sulfate 40 mg / 1 mL intraocular injection, 0.5 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4503581000168110 hyaluronate sodium 30 mg / 1 mL + sodium chondroitin sulfate 40 mg / 1 mL intraocular injection, 0.5 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4503591000168113 sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe Is a chondroitin sulfate + hyaluronate sodium true Inferred relationship Some
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe Is a medicinal product unit of use true Inferred relationship Some
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has manufactured dose form intraocular injection true Inferred relationship Some
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has intended active ingredient hyaluronate sodium true Inferred relationship Some 1158464196
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has Australian BoSS hyaluronate sodium true Inferred relationship Some 1158464196
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has Australian BoSS sodium chondroitin sulfate true Inferred relationship Some 1188512556
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has intended active ingredient chondroitin sulfate true Inferred relationship Some 1188512556
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe has unit of use syringe true Inferred relationship Some 1186232700
Inbound Relationships Type Active Source Characteristic Refinability Group
Viscoat intraocular injection, 0.5 mL syringe Is a True sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe Inferred relationship Some
sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe has MPUU True sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe Inferred relationship Some 1778920975

Reference Sets

Medicinal product unit of use reference set

Back to Start